SGLT2 INHIBITORS COMPARED WITH SITAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES- A SYSTEMATIC REVIEW AND META-ANALYSIS
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1311
https://www.valueinhealthjournal.com/article/S1098-3015(16)01379-6/fulltext
Title :
SGLT2 INHIBITORS COMPARED WITH SITAGLIPTIN AS ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES- A SYSTEMATIC REVIEW AND META-ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01379-6&doi=10.1016/j.jval.2016.03.1311
First page :
A197
Section Title :
Diabetes/Endocrine Disorders - Clinical Outcomes Studies
Open access? :
No
Section Order :
597